Cytokines in Lysosomal Storage Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: closed (31 December 2020) | Viewed by 2813
Special Issue Editor
Interests: genetic and neurodegenerative diseases; complement; cytokines; innate and adaptive immunity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In many of the lysosomal storage diseases (LSDs), including the Gaucher, Fabry, Tay–Sachs, Sandhoff, Niemann–Pick, Farbar, Krabbe, Metachromatic Leukodystrophy, Wolmen, and Mucopolysaccharidoses diseases, the pathological consequences of the accumulation of certain lipids and complex sugars in tissues include the generation of a massive amount of pro-inflammatory cytokines, including interleukin-1α (IL-1α), interleukin-1β (IL-β), tumor necrosis factor alpha (TNFα), interferon gamma (IFNγ), IL-6, IL-8, IL-10, IL-12, and IL-17. These cytokines are linked to the inflammation and destruction of tissue (e.g., liver, spleen, lung, kidney, bone, and brain tissue) in LSDs. The cost to treat most LSD patients with enzyme replacement or substrate reduction therapy is very expensive: approximately $100,000–300,000 per year. The effects of such therapies are limited as they decrease the accumulation of several types of lipids and complex sugars in tissues but are less effective at preventing the innate and adaptive immune inflammation that leads to organ dysfunction and destruction in LSDs. It is clear that additional therapies are needed to address major disease manifestations. In this Special Issue, we aim to systematically survey recently identified cytokines and their role in the propagation of disease complications in different LSDs. Clinical strategies for targeting cytokines and/or their receptors could help us to slow down and/or stop lipid- and complex-sugar-induced tissue inflammation in different LSDs.
Dr. Manoj K. Pandey
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
